Abstract
The long term effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis in mice were tested under two different treatment protocols. A prophylactic experiment examined the effects of the daily drug administration for 180 days beginning one day before the first collagen injection. Under this dosage schedule, cyclophosphamide and cyclosporin decreased the severity of arthritis, while indomethacin did not. A therapeutic protocol examined the effects of these same drugs when daily administration was delayed until the animals had active disease at 78 days after the first collagen injection. Under this protocol, all three drugs reduced the progression of disease. In both protocols, the most significant suppression of arthritis was seen in animals receiving cyclophosphamide which was associated with a decrease in anti-collagen antibody levels. Collagen-induced arthritis in mice should be further investigated as a model to study the long term effects of “slow-acting” anti-rheumatic drugs.
Similar content being viewed by others
References
P. H. Wooley, H. S. Luthra, J. M. Stuart and C. S. David,Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I relgion) linkage and antibody correlates. J. Exp. Med.154, 688–700 (1981).
M. Cremer,Type II collagen-induced arthritis in rats. InHandbook of Animal Models for the Rheumatic Disease. Volume 1 (Eds. R. A. Greenwald and H. S. Diamond) pp. 17–27, CRC Press, Boca Raton, Florida 1988.
J. M. Stuart, L. K. Myers, A. S. Townes and A. H. Kang,Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest.69, 673–683 (1982).
J. S. Courtenay, M. J. Dallman, A. D. Dayan, A. Martin and B. Mosedale,Immunisation against heterologous type II collagen induces arthritis in mice. Nature283, 666–668 (1980).
M. M. Griffiths, E. J. Eichwald, J. H. Martin, C. B. Smith and C. W. DeWitt,Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arth. Rheum.24, 781–789 (1981).
M. M. Griffiths and C. W. DeWitt,Immunogenetic control of experimental collagen-induced arthritis in rats. II. ECIA susceptibility and immune response to type II collagen (calf) are linked to RT1. J. Immunogen.8, 463–470 (1981).
J. S. Garvey, N. E. Cremer and D. H. Sussdorf,Methods in Immunology: a lab text for instruction and research. (3rd edition) pp. 301–312, The Benjamin cummings Publishing Company, Reading, MA, 1977.
K. Phadke, R. L. Fouts, J. E. Parrish and L. D. Butler,Evaluation of the effects of various anti-arthritic drugs on type II collagen-induced mouse arthritis model. Immunopharm.10, 51–60 (1985).
C. Rordorf, A. Pataki, V. Nogues, F. Schlager, U. Feige and M. Glatt,Arthritis in MRL/lpr mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Int. J. Tiss.9, 341–347 (1987).
W. Paska, K. J. McDonald and M. Croft,Studies on type II collagen induced arthritis in mice. Agents and Actions18, 413–420 (1986).
A. E. Sloboda, J. E. Birnbaum, A. L. Oronsky and S. S. Kerwar,Studies on type II collagen-induced polyarthritis in rats. Effects of anti-inflammatory and anti-rheumatic agents. Arthritis and Rheum.24, 616–624 (1981).
K. Takagishi, N. Kaibara, T. Hotokebuchi, C. Arita, M. Morinaga and K. Arai,Effects of cyclosporin on collagen induced arthritis in mice. Ann. Rheum. Dis.45, 339–344 (1986).
N. Kaibara, T. Hotokebuchi, K. Takagishi, I. Katsuki, M. Morinaga, C. Arita and S. Jingushi,Pathogenetic difference between collagen arthritis and adjuvant arthritis. J. Exp. Med.159, 1388–1396 (1984).
J. T. Hom, L. D. Butler, P. E. Riedl and A. M. Bendele,The progression of the inflammation in established collagen-induced arthritis can be altered by treatment with immunological or pharmacological agents which inhibit T-cell activities, Eur. J. Immunol.18, 881–888 (1988).
A. W. Probert Jr., D. J. Schrier and R. B. Gilbertsen,Effects of Antiarthritic compounds on type II collagen-induced arthritis in rats. Arch. Int. Pharm.269, 167–176 (1984).
A. J. Lewis, R. P. Carlson, J. Chang and F. DeLustro,Effect of gold salts, d-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats. Agents and Actions14, 707–714 (1984).
K. Phadke, J. Carroll and S. Nanda,Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats. Clin. Exp. Immun.47, 579–586 (1982).
S. S. Kerwar and A. E. Sloboda,Studies on the effect of fenbufen and sulindac on type II collagen-included arthritis in rats. Agents and Actions12, 216–220 (1982).
N. Seki, Y. Sudo, T. Yoshioka, S. Sugihara, T. Fujitsu, S. Sakuma, T. Ogawa, T. Hamaoka, H. Senoh and H. Fujiwara,Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J. Immunol.140, 1477–1484 (1988).
R. Holmdahl, L. Klareskog, K. Rubin, E. Larsson and H. Wigzell,T-Lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scan. J. Immun.22, 295–306 (1985).
P. H. Wooley, H. S. Luthra, C. H. Krco, J. M. Stuart and C. S. David,Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of antitype II collagen antibody or free native type II collagen.Arthritis and Rheum. 27, 1010–1017 (1984).
J. M. Stuart, L. K. Myers, A. S. Townes and A. H. Kang,Effect of cyclophosphamide, hydrocortisone, and levamisole on collagen-induced arthritis in rats. Arthritis and Rheum.24, 790–794 (1981).
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from Pennwalt Pharmaceutical Company, Rochester, NY, the Veterans Administration Medical Research program, Nora Eccles Treadwell Foundation, and grants from the National Institutes of Health AR-02255 and AM30763.
Rights and permissions
About this article
Cite this article
Cannon, G.W., McCall, S., Cole, B.C. et al. Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice. Agents and Actions 29, 315–323 (1990). https://doi.org/10.1007/BF01966463
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01966463